Fig. 3.
Fig. 3.
The schematic viable viral shedding kinetics between non-immunocompromised patients and immunocompromised patients with COVID-19.
Korean J healthc assoc Infect Control Prev 2023;28:4~9 https://doi.org/10.14192/kjicp.2023.28.1.4
© Korean J healthc assoc Infect Control Prev